Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Koichiro Takahashi, Hiroki Tashiro, Ryo Tajiri, Ayako Takamori, Masaru Uchida, Go Kato, Yuki Kurihara, Hironori Sadamatsu, Takashi Kinoshita, Makoto Yoshida, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane & Tomotaka Kawayama. (2021) Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3297-3307.
Read now
Read now
Koichiro Takahashi, Masaru Uchida, Go Kato, Ayako Takamori, Takashi Kinoshita, Makoto Yoshida, Ryo Tajiri, Keisuke Kojima, Hiroshi Inoue, Hiromi Kobayashi, Hironori Sadamatsu, Hiroki Tashiro, Masahide Tanaka, Shinichiro Hayashi, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane & Tomotaka Kawayama. (2020) First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2115-2126.
Read now
Read now
Shohei Kawachi & Keisaku Fujimoto. (2020) Metronome-Paced Incremental Hyperventilation May Predict Exercise Tolerance and Dyspnea as a Surrogate for Dynamic Lung Hyperinflation During Exercise. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1061-1069.
Read now
Read now
Yoshiaki Minakata, Takashi Motegi, Jun Ueki, Yasuhiro Gon, Shuhei Nakamura, Tatsuhiko Anzai, Kazuto Hirata & Masakazu Ichinose. (2019) Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1789-1801.
Read now
Read now
Arschang Valipour, Michael Tamm, Jana Kociánová, Valentina Bayer, Maria Sanzharovskaya, Alexey Medvedchikov, Monika Haaksma-Herczegh, János Mucsi, Zvi Fridlender, Claudia Toma, Andrey Belevskiy, Bohumil Matula & Jurij Šorli. (2019) Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2343-2354.
Read now
Read now
Shohei Kawachi & Keisaku Fujimoto. (2019) Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1167-1176.
Read now
Read now
Articles from other publishers (19)
Yoshiaki Minakata, Yuichiro Azuma, Seigo Sasaki & Yusuke Murakami. (2023) Objective Measurement of Physical Activity and Sedentary Behavior in Patients with Chronic Obstructive Pulmonary Disease: Points to Keep in Mind during Evaluations. Journal of Clinical Medicine 12:9, pages 3254.
Crossref
Crossref
Yoriyuki Murata, Tsunahiko Hirano, Keiko Doi, Ayumi Fukatsu-Chikumoto, Kazuki Hamada, Keiji Oishi, Tomoyuki Kakugawa, Masafumi Yano & Kazuto Matsunaga. (2023) Computed Tomography Lung Density Analysis: An Imaging Biomarker Predicting Physical Inactivity in Chronic Obstructive Pulmonary Disease: A Pilot Study. Journal of Clinical Medicine 12:8, pages 2959.
Crossref
Crossref
Kazuya Tanimura, Susumu Sato, Yukio Fujita, Yoshifumi Yamamoto, Takashi Hajiro, Nobuyuki Horita, Tomotaka Kawayama & Shigeo Muro. (2023) The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Chronic Respiratory Disease 20, pages 147997312311660.
Crossref
Crossref
Marc Miravitlles, Juan Luís García-Rivero, Xavier Ribera, Jordi Galera, Alejandra García, Rosa Palomino & Xavier Pomares. (2022) Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis. Respiratory Research 23:1.
Crossref
Crossref
Marc Miravitlles, Tomotaka Kawayama & Michael Dreher. (2022) LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations. Journal of Clinical Medicine 11:22, pages 6623.
Crossref
Crossref
Hiroshi Okamoto, Yusuke Taniyama, Tadashi Sakurai, Gaku Kodama, Chiaki Sato, Toshiaki Fukutomi, Yohei Ozawa, Hirotaka Ishida, Ken Koseki, Takuro Yamauchi, Toru Nakano, Michiaki Unno & Takashi Kamei. (2022) Perioperative Administration of Cystine and Theanine Suppresses Inflammation and Facilitates Early Rehabilitation and Recovery after Esophagectomy: A Randomized, Double-Blind, Controlled Clinical Trial. Nutrients 14:11, pages 2319.
Crossref
Crossref
Shigeo Muro, Masaru Suzuki, Shuhei Nakamura, Jocelyn Ruoyi Wang, Elizabeth M. Garry, Wataru Sakamoto & Sabrina de Souza. (2021) Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score–matched cohort analysis. Respiratory Research 22:1.
Crossref
Crossref
J. Molina París, P.M. Alonso Hernández, J.A. Díez García, I. Gonzalez Uribe-Etxebarria, J. Yelo García, J. Galera Llorca, H. Aguilar & X. Ribera. (2021) Assessment of physical functioning in patients with chronic obstructive pulmonary disease (COPD) requiring long-acting dual bronchodilation in routine clinical practice. Medicina de Familia. SEMERGEN 47:5, pages 295-304.
Crossref
Crossref
Dave Singh, James F. Donohue, Isabelle H. Boucot, Neil C. Barnes, Chris Compton & Fernando J. Martinez. (2021)
Future concepts in bronchodilation for COPD: dual-
versus
monotherapy
. European Respiratory Review 30:160, pages 210023.
Crossref
Crossref
M. Zysman, B. Ribeiro Baptista, T. Soumagne, V. Marques da Silva, C. Martin, C. Thibault de Menonville, L. Boyer, B. Degano, C. Morelot Panzini, P.R. Burgel, T. Perez, A. Bourdin, C. Raherison, H. Pégliasco, D. Piperno, C. Zanetti, H. Morel, B. Delclaux, C. Delafosse, A. Lorenzo, B. Housset, F. Chabot, P. Devillier, G. Deslée & N. Roche. (2021) Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021. Revue des Maladies Respiratoires 38:5, pages 539-561.
Crossref
Crossref
Mauro Carone, Alfio Pennisi, Mariella D’Amato, Alfeo Fiore Donati, Alberto Ricci, Carla Scognamillo, Li Chun, Maria Aliani, Valeria Ronsivalle & Girolamo Pelaia. (2020) Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in Italy. Pulmonary Therapy 6:2, pages 261-274.
Crossref
Crossref
Yoshiaki Minakata & Seigo Sasaki. (2020) Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients. Journal of Clinical Medicine 9:11, pages 3497.
Crossref
Crossref
Angela T Burge, Narelle S Cox, Michael J Abramson & Anne E Holland. (2020) Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Duc Ha & Andrew L. Ries. (2020) Characterization of Dyspnea in Veteran Lung Cancer Survivors Following Curative-Intent Therapy. Journal of Cardiopulmonary Rehabilitation and Prevention 40:2, pages 120-127.
Crossref
Crossref
Yoshiaki Minakata. (2019) Progress of Physical Activity Study in Patients with Chronic Obstructive Pulmonary Disease慢性閉塞性肺疾患患者に対する身体活動性研究の進歩. Nihon Naika Gakkai Zasshi 108:12, pages 2554-2560.
Crossref
Crossref
Hannah A. Blair. (2019) Tiotropium/Olodaterol: A Review in COPD. Drugs 79:9, pages 997-1008.
Crossref
Crossref
Tudor P. Toma. (2019) The Coming of Age of Endoscopic Lung Volume Reduction. Journal of Bronchology & Interventional Pulmonology 26:2, pages 75-77.
Crossref
Crossref
Chin Kook Rhee, Hajime Yoshisue & Rahul Lad. (2019) Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Advances in Therapy 36:3, pages 495-519.
Crossref
Crossref
Eric Derom, Guy G. Brusselle & Guy F. Joos. (2019) The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects. Therapeutic Advances in Respiratory Disease 13, pages 175346661984342.
Crossref
Crossref